首页> 外文期刊>BioScience >Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes
【24h】

Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes

机译:二甲双胍(单独或与胰岛素一起使用)与预防妊娠糖尿病中围产期并发症的效果一样好

获取原文
获取原文并翻译 | 示例
           

摘要

QuestionnnIn gestational diabetes, is metformin (plus insulin as needed) as effective as insulin for preventing perinatal complications?nnMethodsnnDesign: Randomized controlled trial (Metformin in Gestational Diabetes [MiG] Trial).nnAllocation: {Concealed}†.*nnBlinding: Unblinded.*nnFollow-up period: 6 to 8 weeks postpartum.nnSetting: 10 obstetric hospitals in New Zealand and Australia.nnPatients: 751 women 18 to 45 years of age (mean age 33 y) who were 20- to 33-weeks pregnant with a single healthy fetus and had gestational diabetes requiring medical treatment (fasting blood glucose > 5.4 mmol/L [97.2 mg/dL] or 2-hour postprandial blood glucose > 6.7 mmol/L [120.6 mg/dL] on > 1 occasion after lifestyle intervention). Exclusion criteria included prepregnancy diabetes, hypertensive disorders, and ruptured membranes.nnIntervention: Metformin, 500 mg once or twice daily, increased to a maximum of 2500 mg/d, with insulin added as needed (n = 373) or insulin administered according to each center's standard practice (n = 378). Target levels were < 5.5 mmol/L (99 mg/dL) for fasting and < 7.0 mmol/L (126 mg/dL) for 2-h postprandial blood glucose (or less).nnOutcomes: Composite neonatal outcome (hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-min Apgar score < 7, or preterm birth) and maternal hypertensive complications and weight gain. The study had 80% power to detect an absolute difference of 10% in the primary composite outcome with an alpha level of 0.05.nnPatient follow-up: 98% (intention-to-treat analysis).nnnMain resultsnnGroups did not differ for the composite neonatal outcome or any of its components, except for severe hypoglycemia and preterm birth (Table). Groups did not differ for gestational hypertension or preeclampsia. Women in the metformin group gained less weight (0.4 vs 2.0 kg, P < 0.001). nnConclusionnnIn gestational diabetes, metformin (plus insulin as needed) was as effective as insulin for preventing perinatal complications.
机译:Questionnn在妊娠糖尿病中,二甲双胍(根据需要加胰岛素)是否能与胰岛素有效地预防围产期并发症?nnMethodsnnDesign:随机对照试验(妊娠糖尿病中的二甲双胍[MiG]试验)。nn分配:{隐含}†。* nn盲:无盲。 nn随访时间:产后6至8周nn地点:新西兰和澳大利亚的10家产科医院nn患者:751名18至45岁(平均年龄为33岁)的妇女,单胎怀孕20至33周健康的胎儿并患有妊娠糖尿病,需要治疗(生活方式干预后> 1次,空腹血糖> 5.4 mmol / L [97.2 mg / dL]或餐后2小时血糖> 6.7 mmol / L [120.6 mg / dL]) 。排除标准包括孕前糖尿病,高血压疾病和膜破裂。nn干预:二甲双胍,每日一次或两次,每次500 mg,增加至最高2500 mg / d,并根据需要添加胰岛素(n = 373)或根据每种药物给予胰岛素中心的标准做法(n = 378)。禁食的目标水平为<5.5 mmol / L(99 mg / dL),餐后2小时血糖(或更低)的目标水平为<7.0 mmol / L(126 mg / dL).nn结果:新生儿综合结局(低血糖,呼吸窘迫) ,需要光疗,出生创伤,5分钟Apgar得分<7或早产)以及孕妇高血压并发症和体重增加。该研究有80%的能力可以检测出主要复合结果的绝对差异为10%,α水平为0.05.nn患者随访:98%(意向性治疗分析).nnn主要结果新生儿结局或其任何组成部分,严重低血糖症和早产除外(表)。妊娠高血压或先兆子痫的人群没有差异。二甲双胍组的女性体重减轻(0.4 vs 2.0 kg,P <0.001)。结论在妊娠糖尿病中,二甲双胍(根据需要加胰岛素)在预防围产期并发症方面与胰岛素一样有效。

著录项

  • 来源
    《BioScience》 |2008年第2期|p.7-7|共1页
  • 作者

    Anna P. Kenyon MBChB MD;

  • 作者单位

    Kings College LondonLondon, United Kingdom;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号